Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology
Patent
1993-11-30
1998-05-12
Rories, Charles C. P.
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of regulating cell metabolism or physiology
435 691, 435 911, 4351721, 4351723, 4353201, 435377, 435325, 514 44, 4241991, C12N 510, C12N 1585, C12N 1586, A61K 4800
Patent
active
057503982
ABSTRACT:
This invention relates to the use of Herpes Simplex Virus (HSV) immediate early protein ICP47, nucleic acid sequences coding for ICP47, and homologous proteins and nucleic acid sequences, to inhibit presentation of viral and cellular antigens associated with major histocompatibility class I (MHC class I) proteins to CD8+ T lymphocytes; this inhibition effectively increases infective persistence, which can, for example, improve the utility of viral gene therapy vectors. This invention also pertains to a method for the treatment of herpesvirus infections, wherein expression and/or activity of the ICP47 protein or its homologue is inhibited in order to increase immune recognition of herpesvirus-infected cells and other cells. This invention also pertains to a method for identifying drugs that interfere with the expression or function of ICP47 and its homologues, and which are useful in treating herpesvirus infections, and also pertains to the drugs so identified. Furthermore, this invention pertains to methods for the treatment and prevention of autoimmune diseases, tissue and organ transplant rejection, diabetes, multiple sclerosis, arthritis, and tissue damage accompanying ocular herpesvirus infections, wherein ICP47 or its homologue, or nucleic acids encoding such proteins, are introduced into the cells of a patient. In addition, this invention pertains to vector elements, vectors, polypeptides and polypeptide fragments that can be utilized for the forgoing purposes.
REFERENCES:
A. Coghland, New Scientist, 25 Nov. '95, pp. 14-15.
D. Brown, Washington Post, Friday, 8 Dec. '95, pp. A1 & A22.
Koelle et al. J. Clin. Invest., vol. 91 (Mar. 1993) pp. 961-968.
A. Sinha et al. Science, vol. 248 (Jun. 15, 1990) pp. 1380-1388.
R. Mulligan. Science, vol. 260 (May 14, 1993) pp. 926-932.
A. Byrnes et al. Newscience, vol. 66, #4 ('95) pp. 1015-1024.
N. Dillon TIBTECH, vol. 11 ('93) pp. 167-173.
G. Roeck et al., Cell, vol. 50 (Aug. 28, 1987) pp. 667.
C. Posavad et al. J. Virology, (Nov. '92) vol. 66 #11, pp. 6264-6272.
D. Fausman et al. Science, vol. 252 (Jun. 21, 1991) pp. 1700-1702.
M. Rosefeld et al. Science, vol. 28 (Apr. '91) pp. 431-434.
T. Kay et al. (abstract) Diaberologia, vol. 34(11) pp. 779-785 (Nov. '91).
R. Siegel et al (abstract) Immunol. Rev., vol. 118 ('90) pp. 165-192.
B. Ksarder et al. (abstract) Invest. Ophtolmol. Vis. Sci., ('87) vol. 28(12) pp. 1986-1993.
A. Riddersrad et al. J. Aroimmunul., vol. 5 (3) ('92), pp. 333-350.
Palfreyman, et al., "Successful Use of Oligopeptides as Immunogens in the Preparation of Antisera to Immediate-Early Gene Products of Herpes Simplex Virus Type 1," The Journal of General Virology, The Society for General Microbiology, vol. 65, Part 5, pp. 865-874 (1984).
Persson, et al., "Cells that Constitutively Express the Herpes Simplex Virus Immediate-Early Protent ICP4 Allow Efficient Activation of Viral Delayed-Early Genes in trans," The Journal of General Virology, American Society for Microbiology, vol. 54, No. 2, pp. 414-421 (1985).
McGeoch, et al., "Sequence Determination and Genetic Content of the Short Unique Region in the Genome of Herpes Simplex Virus Type 1," Journal of Molecular Biology, Academic Press Inc. (London) Ltd., vol. 181, pp. 1-13 (1985).
Carter, et al., "Mapping of a Herpes Simplex Virus Type 2-Encoded Function That Affects the Susceptibility of Herpes Simplex-Infected Target Cells to Lysis by Herpes Simplex Virus-Specific Cytotoxic T Lymphocytes," Journal of Virology, American Society for Microbiology, vol. 49, No. 3, pp. 766-771 (1984).
Fletcher III, et al., "DNA Sequence and Genetic Organization of the Unique Short (U.sub.s) Region of the Simian Varicella Virus Genome," Virology Academic Press, Inc., vol. 193, pp. 762-773 (1993).
McGeoch, et al., "The Complete DNA Sequence of the Long Unique Region in the Genome of Herpes Simplex Virus Type 1," Journal of General Virology, SGM, vol. 69, pp. 1531-1547 (1988).
McGeoch, et al., "Herpes Simplex Virus" (1992).
Mavromara-Nazos, et al., "Construction and Properties of a Viable Herpes Simplex Virus 1 Recombinant Lacking Coding Sequences of the .alpha.47 Gene," Journal of Virology, American Society for Microbiology, vol. 60, No. 2, pp. 807-812 (1986).
Nishiyama, et al., "The US 9, 10, 11, and 12 Genes of Herpes Simplex Virus Type 1 Are of No Importance for Its Neurovirulence and Latency in Mice," Virology, Academic Press, Inc., vol. 194, pp. 419-423 (1993).
Whitely, "Herpes Simplex Viruses," Virology, Raven Press, Ltd., Chapter 66, pp.1843-1887 (1990).
Marsden, et al., "Genomic Location and Lack of Phosphorylation of the HSV Immediate-Early Polypeptide IE 12," Journal of General Virology, SGM, vol. 62, pp. 17-27 (1982).
Davidson, et al., "Evolutionary Comparisons of the S Segments in the Genomes of Herpes Simplex Virus Type 1 and Varicella-Zoster Virus," Journal of General Virology, SGM, vol. 67, pp. 597-611 (1986).
Zhang, et al., "The structure of the pseudorabies virus genome at the end of the inverted repeat sequences proximal to the junction with the short unique region," Journal of General Virology, SGM, vol. 71, pp. 2433-2441 (1990).
Umene, "Conversion of a Fraction of the Unique Sequence to Part of the Inverted Repeats in the S Component of the Herpes Simplex Virus Type 1 Genome," Journal of General Virology, SGM, vol. 67, pp. 1035-1048 (1986).
Johnson, et al., "Intracellular Transport of Herpes Simplex Virus gD Occurs More Rapidly in Uninfected Cells that in Infected Cells," Journal of Virology, American Society for Microbiology, vol. 54, No. 3, pp. 682-689 (1985).
del Val, et al., "Cytomegalovirus Prevents Antigen Presentation by Blocking the Transport of Peptide-loaded Major Histocompatibility Complex Class I Molecules into the Medial-Golgi Compartment," J. Exp. Med. The Rockfeller University Press, vol. 176, pp. 729-738 (1992).
Gooding, "Virus Proteins That Counteract Host Immune Defenses," Minireview, Cell Press, vol. 71, pp. 5-7 (1992).
Mellencamp et al., "Pseudorabies Virus-Induced Suppression of Major Histovompatibility Complex Class I Antigen Expression," Journal of Virology, American Society of Microbiology, vol. 65, No. 6, pp. 3365-3368 (1991).
Johnson David C.
York Ian A.
Johnson David C.
Rories Charles C. P.
York Ian A.
LandOfFree
Vector, element and method for inhibiting immune recognition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vector, element and method for inhibiting immune recognition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vector, element and method for inhibiting immune recognition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-978509